Taken together, the SHH-HSP90β-miR-28-5p axis offers promising therapeutic targets against NASH, and serum miR-28-5p may serve as a NASH diagnostic biomarker. The gene discussed is SHH; the disease is metabolic dysfunction-associated steatohepatitis.